China Traditional Chinese Medicine Holdings Co. Limited (0570.HK)
HKD 2.31
(-0.86%)
HKD 2.31
(-0.86%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 9.27 Billion CNY | 28.84% |
| 2022 | 7.19 Billion CNY | -39.15% |
| 2021 | 11.82 Billion CNY | 29.62% |
| 2020 | 9.12 Billion CNY | 6.42% |
| 2019 | 8.57 Billion CNY | 38.46% |
| 2018 | 6.19 Billion CNY | 33.15% |
| 2017 | 4.65 Billion CNY | 22.81% |
| 2016 | 3.78 Billion CNY | 72.64% |
| 2015 | 2.19 Billion CNY | 32.62% |
| 2014 | 1.65 Billion CNY | 100.33% |
| 2013 | 825.77 Million CNY | 47.94% |
| 2012 | 558.18 Million CNY | 25.76% |
| 2011 | 443.84 Million CNY | -0.59% |
| 2010 | 446.48 Million CNY | 57.15% |
| 2009 | 284.11 Million CNY | 103.86% |
| 2008 | 139.36 Million CNY | 19.5% |
| 2007 | 116.62 Million CNY | 173.88% |
| 2006 | 42.58 Million CNY | 140.08% |
| 2005 | -106.24 Million CNY | -1318.76% |
| 2004 | -7.48 Million CNY | -109.1% |
| 2003 | 82.25 Million CNY | -59.24% |
| 2002 | 201.79 Million CNY | 42.84% |
| 2001 | 141.27 Million CNY | 44.26% |
| 2000 | 97.93 Million CNY | -64.45% |
| 1999 | 275.46 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 2.03 Billion CNY | -10.08% |
| 2024 Q2 | 2.03 Billion CNY | 0.0% |
| 2023 Q1 | 2.37 Billion CNY | 12.04% |
| 2023 Q3 | 2.25 Billion CNY | -5.07% |
| 2023 FY | 9.27 Billion CNY | 28.84% |
| 2023 Q4 | 2.25 Billion CNY | 0.0% |
| 2023 Q2 | 2.37 Billion CNY | 0.0% |
| 2022 Q2 | 1.47 Billion CNY | 0.0% |
| 2022 Q1 | 1.47 Billion CNY | -56.76% |
| 2022 FY | 7.19 Billion CNY | -39.15% |
| 2022 Q4 | 2.12 Billion CNY | 0.0% |
| 2022 Q3 | 2.12 Billion CNY | 43.86% |
| 2021 Q3 | 3.41 Billion CNY | 36.45% |
| 2021 Q4 | 3.41 Billion CNY | 0.0% |
| 2021 FY | 11.82 Billion CNY | 29.62% |
| 2021 Q1 | 2.5 Billion CNY | -2.08% |
| 2021 Q2 | 2.5 Billion CNY | 0.0% |
| 2020 FY | 9.12 Billion CNY | 6.42% |
| 2020 Q3 | 2.55 Billion CNY | 27.19% |
| 2020 Q2 | 2 Billion CNY | 0.0% |
| 2020 Q4 | 2.55 Billion CNY | 0.0% |
| 2020 Q1 | 2 Billion CNY | -8.47% |
| 2019 Q4 | 2.19 Billion CNY | 0.0% |
| 2019 Q2 | 2.09 Billion CNY | 0.0% |
| 2019 Q1 | 2.09 Billion CNY | 28.33% |
| 2019 FY | 8.57 Billion CNY | 38.46% |
| 2019 Q3 | 2.19 Billion CNY | 4.81% |
| 2018 Q4 | 1.63 Billion CNY | 0.0% |
| 2018 FY | 6.19 Billion CNY | 33.15% |
| 2018 Q3 | 1.63 Billion CNY | 11.33% |
| 2018 Q2 | 1.46 Billion CNY | 0.0% |
| 2018 Q1 | 1.46 Billion CNY | 18.09% |
| 2017 FY | 4.65 Billion CNY | 22.81% |
| 2017 Q4 | 1.24 Billion CNY | 0.0% |
| 2017 Q1 | 1.08 Billion CNY | 11.05% |
| 2017 Q3 | 1.24 Billion CNY | 14.38% |
| 2017 Q2 | 1.08 Billion CNY | 0.0% |
| 2016 Q1 | 916.84 Million CNY | 36.44% |
| 2016 FY | 3.78 Billion CNY | 72.64% |
| 2016 Q4 | 976.99 Million CNY | 0.0% |
| 2016 Q3 | 976.99 Million CNY | 6.56% |
| 2016 Q2 | 916.84 Million CNY | 0.0% |
| 2015 Q4 | 671.98 Million CNY | 0.0% |
| 2015 Q1 | 428.35 Million CNY | -2.97% |
| 2015 FY | 2.19 Billion CNY | 32.62% |
| 2015 Q2 | 428.35 Million CNY | 0.0% |
| 2015 Q3 | 671.98 Million CNY | 56.88% |
| 2014 Q4 | 441.48 Million CNY | 0.0% |
| 2014 FY | 1.65 Billion CNY | 100.33% |
| 2014 Q3 | 441.48 Million CNY | 16.11% |
| 2014 Q2 | 380.21 Million CNY | 0.0% |
| 2014 Q1 | 380.21 Million CNY | 44.3% |
| 2013 Q2 | 149.39 Million CNY | 0.0% |
| 2013 Q4 | 263.49 Million CNY | 0.0% |
| 2013 Q3 | 263.49 Million CNY | 76.38% |
| 2013 FY | 825.77 Million CNY | 47.94% |
| 2013 Q1 | 149.39 Million CNY | -3.94% |
| 2012 Q1 | 139.54 Million CNY | 0.0% |
| 2012 Q2 | 139.54 Million CNY | 0.0% |
| 2012 Q3 | 154.48 Million CNY | 10.7% |
| 2012 Q4 | 155.52 Million CNY | 0.67% |
| 2012 FY | 558.18 Million CNY | 25.76% |
| 2011 Q1 | 110.96 Million CNY | 0.0% |
| 2011 FY | 443.84 Million CNY | -0.59% |
| 2011 Q4 | 139.54 Million CNY | 25.76% |
| 2011 Q3 | 110.96 Million CNY | 0.0% |
| 2011 Q2 | 110.96 Million CNY | 0.0% |
| 2010 Q4 | 110.96 Million CNY | -0.59% |
| 2010 FY | 446.48 Million CNY | 57.15% |
| 2010 Q3 | 111.62 Million CNY | 0.0% |
| 2010 Q1 | 111.62 Million CNY | 0.0% |
| 2010 Q2 | 111.62 Million CNY | 0.0% |
| 2009 Q3 | 71.02 Million CNY | 0.0% |
| 2009 Q1 | 71.02 Million CNY | 0.0% |
| 2009 Q2 | 71.02 Million CNY | 0.0% |
| 2009 Q4 | 111.62 Million CNY | 57.15% |
| 2009 FY | 284.11 Million CNY | 103.86% |
| 2008 Q1 | 34.84 Million CNY | 0.0% |
| 2008 FY | 139.36 Million CNY | 19.5% |
| 2008 Q4 | 71.02 Million CNY | 103.86% |
| 2008 Q3 | 34.84 Million CNY | 0.0% |
| 2008 Q2 | 34.84 Million CNY | 0.0% |
| 2007 Q3 | 29.15 Million CNY | 0.0% |
| 2007 Q4 | 34.84 Million CNY | 19.5% |
| 2007 FY | 116.62 Million CNY | 173.88% |
| 2007 Q1 | 29.15 Million CNY | 0.0% |
| 2007 Q2 | 29.15 Million CNY | 0.0% |
| 2006 Q1 | 10.64 Million CNY | 0.0% |
| 2006 FY | 42.58 Million CNY | 140.08% |
| 2006 Q4 | 29.15 Million CNY | 173.88% |
| 2006 Q3 | 10.64 Million CNY | 0.0% |
| 2006 Q2 | 10.64 Million CNY | 0.0% |
| 2005 Q2 | -26.56 Million CNY | 0.0% |
| 2005 Q4 | 10.64 Million CNY | 140.08% |
| 2005 Q3 | -26.56 Million CNY | 0.0% |
| 2005 Q1 | -26.56 Million CNY | 0.0% |
| 2005 FY | -106.24 Million CNY | -1318.76% |
| 2004 Q2 | -1.87 Million CNY | 0.0% |
| 2004 Q3 | -1.87 Million CNY | 0.0% |
| 2004 Q4 | -26.56 Million CNY | -1318.76% |
| 2004 FY | -7.48 Million CNY | -109.1% |
| 2004 Q1 | -1.87 Million CNY | 0.0% |
| 2003 Q1 | 20.56 Million CNY | 0.0% |
| 2003 FY | 82.25 Million CNY | -59.24% |
| 2003 Q4 | -1.87 Million CNY | -109.1% |
| 2003 Q2 | 20.56 Million CNY | 0.0% |
| 2003 Q3 | 20.56 Million CNY | 0.0% |
| 2002 Q2 | 50.44 Million CNY | 0.0% |
| 2002 Q3 | 50.44 Million CNY | 0.0% |
| 2002 FY | 201.79 Million CNY | 42.84% |
| 2002 Q4 | 20.56 Million CNY | -59.24% |
| 2002 Q1 | 50.44 Million CNY | 0.0% |
| 2001 Q2 | 35.31 Million CNY | 0.0% |
| 2001 Q1 | 35.31 Million CNY | 0.0% |
| 2001 FY | 141.27 Million CNY | 44.26% |
| 2001 Q4 | 50.44 Million CNY | 42.84% |
| 2001 Q3 | 35.31 Million CNY | 0.0% |
| 2000 Q2 | 24.48 Million CNY | 0.0% |
| 2000 Q1 | 24.48 Million CNY | 0.0% |
| 2000 FY | 97.93 Million CNY | -64.45% |
| 2000 Q4 | 35.31 Million CNY | 44.26% |
| 2000 Q3 | 24.48 Million CNY | 0.0% |
| 1999 Q2 | 68.86 Million CNY | 0.0% |
| 1999 Q3 | 68.86 Million CNY | 0.0% |
| 1999 Q4 | 24.48 Million CNY | -64.45% |
| 1999 FY | 275.46 Million CNY | 0.0% |
| 1999 Q1 | 68.86 Million CNY | 0.0% |
| 1998 Q4 | 68.86 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 167.43 Million HKD | -5439.127% |
| Grand Pharmaceutical Group Limited | 6.52 Billion HKD | -42.158% |
| Extrawell Pharmaceutical Holdings Limited | 28.77 Million HKD | -32126.596% |
| Wai Yuen Tong Medicine Holdings Limited | 394.81 Million HKD | -2249.085% |
| Qianhai Health Holdings Limited | -35.6 Million HKD | 26149.749% |
| Lee's Pharmaceutical Holdings Limited | 551.31 Million HKD | -1582.261% |
| Essex Bio-Technology Limited | 1.53 Billion HKD | -502.516% |
| Tongfang Kontafarma Holdings Limited | 471.29 Million HKD | -1867.887% |
| PuraPharm Corporation Limited | 216.62 Million HKD | -4181.279% |
| SSY Group Limited | 3.48 Billion HKD | -165.807% |
| JBM (Healthcare) Limited | 319.41 Million HKD | -2803.578% |
| Jacobson Pharma Corporation Limited | 620.47 Million HKD | -1394.741% |
| China Resources Pharmaceutical Group Limited | 43.36 Billion HKD | 78.614% |